Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Sflomos

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Nature Communications|August 25, 2022
Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrencePatrick Aouad, Yueyun Zhang, Fabio De Martino, et al.
EMBO Molecular Medicine|February 22, 2021
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1George Sflomos, Laura Battista, Patrick Aouad, et al.
Cancer Cell|March 8, 2016
A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone ResponseGeorge Sflomos, Valerian Dormoy, Tauno Metsalu, et al.
Science Translational Medicine|April 26, 2013
Progesterone/RANKL is a major regulatory axis in the human breastTamara Tanos, George Sflomos, Pablo C Echeverria, et al.
Cancers|November 13, 2021
Atlas of Lobular Breast Cancer Models: Challenges and Strategic DirectionsGeorge Sflomos, Koen Schipper, Thijs Koorman, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 19, 2020
A novel culture method that sustains ERα signaling in human breast cancer tissue microstructuresAna Luísa Cartaxo, Marta F Estrada, Giacomo Domenici, et al.
Nature Communications|June 6, 2022
Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptorValentina Scabia, Ayyakkannu Ayyanan, Fabio De Martino, et al.
EMBO Molecular Medicine|May 27, 2021
Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferationMarie Shamseddin, Fabio De Martino, Céline Constantin, et al.
Cancer Discovery|April 2, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapiesMarie-Anne Goyette, Christopher Graser, Marco Seehawer, et al.
Nature Communications|January 9, 2025
CDK4 inactivation inhibits apoptosis via mitochondria-ER contact remodeling in triple-negative breast cancerDorian V Ziegler, Kanishka Parashar, Lucia Leal-Esteban, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Nature Communications|August 25, 2022
Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrencePatrick Aouad, Yueyun Zhang, Fabio De Martino, et al.
EMBO Molecular Medicine|February 22, 2021
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1George Sflomos, Laura Battista, Patrick Aouad, et al.
Cancer Cell|March 8, 2016
A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone ResponseGeorge Sflomos, Valerian Dormoy, Tauno Metsalu, et al.
Science Translational Medicine|April 26, 2013
Progesterone/RANKL is a major regulatory axis in the human breastTamara Tanos, George Sflomos, Pablo C Echeverria, et al.
Cancers|November 13, 2021
Atlas of Lobular Breast Cancer Models: Challenges and Strategic DirectionsGeorge Sflomos, Koen Schipper, Thijs Koorman, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 19, 2020
A novel culture method that sustains ERα signaling in human breast cancer tissue microstructuresAna Luísa Cartaxo, Marta F Estrada, Giacomo Domenici, et al.
Nature Communications|June 6, 2022
Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptorValentina Scabia, Ayyakkannu Ayyanan, Fabio De Martino, et al.
EMBO Molecular Medicine|May 27, 2021
Contraceptive progestins with androgenic properties stimulate breast epithelial cell proliferationMarie Shamseddin, Fabio De Martino, Céline Constantin, et al.
Cancer Discovery|April 2, 2026
HER2 heterogeneous breast cancer models reveal novel therapeutic targets and subclonal dynamics during evolution to resistance to HER2-targeted therapiesMarie-Anne Goyette, Christopher Graser, Marco Seehawer, et al.
Nature Communications|January 9, 2025
CDK4 inactivation inhibits apoptosis via mitochondria-ER contact remodeling in triple-negative breast cancerDorian V Ziegler, Kanishka Parashar, Lucia Leal-Esteban, et al.
Pageof 3